DSG2 and lung adenocarcinoma: CAR and DSG2 gene co-expression was higher in early stage lung adenocarcinoma and was shown to have a significantly poorer survival outcome, when compared with lower CAR and DSG2 gene expression (p = 0.0046) (Figure 4).